Q3 2018

Filed Nov 8, 2018 · 10-Q · 39 days after period end · 0001213900-18-015142

Q3 2018 · 10-Q

Revenue—

Net Income

-$47.52K

N/M vs Q3 2017

EPS Diluted

$0.00

— vs Q3 2017

Operating Income-$47,524N/M

Operating Cash Flowderived$16,227−31.8%

Same quarter

Metric	Q3 2018	Q3 2017	Q3 2016	Q3 2015
Revenue	—	$111.98K	$101.14K	$110.78K
Net Income	-$47.52K	$48.88K	-$213.99K	$206.25K
EPS Diluted	$0.00	$0.00	-$0.01	$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Bioxytran, Inc · CIK 1445815 · Engraved from SEC EDGAR